search
Back to results

Non-invasive Ventilation in Preterm Infants

Primary Purpose

Premature Birth, Respiratory Distress Syndrome, Ventilator Lung; Newborn

Status
Recruiting
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Titration procedure
Electrical impedance tomography
Lung and diaphragm ultrasound
Sponsored by
Universitair Ziekenhuis Brussel
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Premature Birth

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Preterm infants (< 37 weeks GA) supported with non-invasive respiratory support. Non-invasive respiratory support can consist of non-invasive NAVA, nasal continuous positive airway pressure (nCPAP) or high flow nasal canula (flow > 2 liters/min).The support can be given as primary respiratory support or as respiratory support after weaning from invasive ventilation (= after extubation). Infants can only be enrolled after written and signed informed consent by the parents. Exclusion Criteria: Infant born after a gestational age of 37 weeks or more. Infants with major congenital malformations or chromosomal abnormalities (eg trisomy 18, congenital diaphragmatic hernia…)

Sites / Locations

  • Universitair Ziekenhuis BrusselRecruiting

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Preterm infants on non-invasive respiratory support

Arm Description

All infants on non-invasive respiratory support will be studied. Only infants on NIV-NAVA, will undergo an intervention.

Outcomes

Primary Outcome Measures

Total duration of respiratory support
Total number of days of invasive and non-invasive respiratory support
Rate of bronchopulmonary dysplasia (BPD) or death
Percentage of infants with BPD or death

Secondary Outcome Measures

Duration of invasive respiratory support (days)
Duration of non-invasive respiratory support (days)
Description of mode of non-invasive respiratory support
Use of NIV-NAVA, CPAP, HHHFNC, oxygen therapy
Use of surfactant and mode of administration
Incidence of nosocomial infection
Use of corticosteroids for the prevention or treatment of BPD
Use of any corticosteroid (systemic or local)
Length of hospital stay
Days of stay in the neonatal unit
Respiratory severity score (RSS)
RSS will be measured during the weaning phase of non-invasive respiratory support
NIV-NAVA breakpoint
Definition of the breakpoint for patients of NIV-NAVA after following a prespecified titration protocol
Lung ultrasound score
Lung ultrasound score will be scored at several time points
Diaphragm ultrasound
Measurement of diaphragm thickness with ultrasound
Silent Spaces
Parts (in % of global lung volume) of the lung that are not ventilated as measured with electrical impedance tomography (EIT)
Tidal volume (TV)
Percentage of TV per 'Region of Interest' (ROI) as measured with electrical impedance tomography (EIT)
Center of Ventilation (CoV)
As measured with electrical impedance tomography (EIT)

Full Information

First Posted
November 2, 2022
Last Updated
August 3, 2023
Sponsor
Universitair Ziekenhuis Brussel
search

1. Study Identification

Unique Protocol Identification Number
NCT05987800
Brief Title
Non-invasive Ventilation in Preterm Infants
Official Title
Non-invasive Ventilation in Preterm Infants
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 1, 2023 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universitair Ziekenhuis Brussel

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a prospective, observational cohort study. For the study part on noninvasive neurally adjusted ventilatory assist (NIV-NAVA) the design is interventional. For all participants prospective data collection will be conducted by chart review and by downloading ventilatory data from the ventilator. A registration of respiratory severity score will be done by a caregiver during the weaning period. This consists of a visual assessment of the work of breathing every 2 hours. For participants on NIV-NAVA consenting to the interventional part of the study a titration procedure will be conducted, afterwards serial electrical impedance tomography and lung and diaphragm ultrasound measurements will be done.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Premature Birth, Respiratory Distress Syndrome, Ventilator Lung; Newborn

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Preterm infants on non-invasive respiratory support
Arm Type
Other
Arm Description
All infants on non-invasive respiratory support will be studied. Only infants on NIV-NAVA, will undergo an intervention.
Intervention Type
Diagnostic Test
Intervention Name(s)
Titration procedure
Intervention Description
The NAVA level will be reduced to 0,5 cmH2O/microvolt (µV) for 3 minutes as a starting point. Limit peak pressure will be set to 35 cmH2O (the maxi-mum pressure that can be delivered to the patient is cut off at 30 cmH2O). Other ventilator settings will be left unchanged and are as clinically indicated. Starting from a NAVA level of 0,5 cmH20/µV the level will be increased by 0,5 cmH2O/µV every 3 minutes until reaching a maximum NAVA level of 2,5 cmH2O/µV.
Intervention Type
Diagnostic Test
Intervention Name(s)
Electrical impedance tomography
Intervention Description
This is a non-invasive technique consisting of the application of a non-adhesive single-use patient belt to monitor regional changes in lung aeration at the bedside.
Intervention Type
Diagnostic Test
Intervention Name(s)
Lung and diaphragm ultrasound
Intervention Description
Lung ultrasound is a non-invasive technique used to diagnose lung pathology and to monitor lung condition. This technique is part of the standard of care for preterm infants in our neonatal unit. Lung ultrasound scores are calculated at each time an ultrasound is performed. Ultrasound of the diaphragm consists of a short additional measurement of diaphragm thickness and thickening fraction and will be done at the same time of the lung ultrasound following a standardized procedure.
Primary Outcome Measure Information:
Title
Total duration of respiratory support
Description
Total number of days of invasive and non-invasive respiratory support
Time Frame
From birth until study completion, variating between 3 weeks and 3 months
Title
Rate of bronchopulmonary dysplasia (BPD) or death
Description
Percentage of infants with BPD or death
Time Frame
From birth until gestational age of 36 weeks
Secondary Outcome Measure Information:
Title
Duration of invasive respiratory support (days)
Time Frame
From birth until study completion, variating between 3 weeks and 3 months
Title
Duration of non-invasive respiratory support (days)
Time Frame
From birth until study completion, variating between 3 weeks and 3 months
Title
Description of mode of non-invasive respiratory support
Description
Use of NIV-NAVA, CPAP, HHHFNC, oxygen therapy
Time Frame
From birth until study completion, variating between 3 weeks and 3 months
Title
Use of surfactant and mode of administration
Time Frame
From birth until study completion, variating between 3 weeks and 3 months
Title
Incidence of nosocomial infection
Time Frame
From birth until study completion, variating between 3 weeks and 3 months
Title
Use of corticosteroids for the prevention or treatment of BPD
Description
Use of any corticosteroid (systemic or local)
Time Frame
From birth until study completion, variating between 3 weeks and 3 months
Title
Length of hospital stay
Description
Days of stay in the neonatal unit
Time Frame
From birth until study completion, variating between 3 weeks and 3 months
Title
Respiratory severity score (RSS)
Description
RSS will be measured during the weaning phase of non-invasive respiratory support
Time Frame
From start of the weaning phase until respiratory support is stopped, up to 10 weeks
Title
NIV-NAVA breakpoint
Description
Definition of the breakpoint for patients of NIV-NAVA after following a prespecified titration protocol
Time Frame
At inclusion (within 24 hours)
Title
Lung ultrasound score
Description
Lung ultrasound score will be scored at several time points
Time Frame
At inclusion, day 3, day 7 and weekly thereafter as long as supported with NIV-NAVA, up to 10 weeks
Title
Diaphragm ultrasound
Description
Measurement of diaphragm thickness with ultrasound
Time Frame
At inclusion, day 3, day 7 and weekly thereafter as long as supported with NIV-NAVA, up to 10 weeks
Title
Silent Spaces
Description
Parts (in % of global lung volume) of the lung that are not ventilated as measured with electrical impedance tomography (EIT)
Time Frame
At inclusion, day 3, day 7 and weekly thereafter as long as supported with NIV-NAVA as long as supported with NIV-NAVA, up to 10 weeks
Title
Tidal volume (TV)
Description
Percentage of TV per 'Region of Interest' (ROI) as measured with electrical impedance tomography (EIT)
Time Frame
At inclusion, day 3, day 7 and weekly thereafter as long as supported with NIV-NAVA as long as supported with NIV-NAVA, up to 10 weeks
Title
Center of Ventilation (CoV)
Description
As measured with electrical impedance tomography (EIT)
Time Frame
At inclusion, day 3, day 7 and weekly thereafter as long as supported with NIV-NAVA as long as supported with NIV-NAVA, up to 10 weeks

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Preterm infants (< 37 weeks GA) supported with non-invasive respiratory support. Non-invasive respiratory support can consist of non-invasive NAVA, nasal continuous positive airway pressure (nCPAP) or high flow nasal canula (flow > 2 liters/min).The support can be given as primary respiratory support or as respiratory support after weaning from invasive ventilation (= after extubation). Infants can only be enrolled after written and signed informed consent by the parents. Exclusion Criteria: Infant born after a gestational age of 37 weeks or more. Infants with major congenital malformations or chromosomal abnormalities (eg trisomy 18, congenital diaphragmatic hernia…)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Julie Lefevere, MD
Phone
024777721
Email
julie.lefevere@uzbrussel.be
First Name & Middle Initial & Last Name or Official Title & Degree
Brenda Van Delft
Email
brenda.vandelft@uzbrussel.be
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Julie Lefevere, MD
Organizational Affiliation
Universitair Ziekenhuis Brussel
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Filip Cools, PhD
Organizational Affiliation
Universitair Ziekenhuis Brussel
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Brenda Van Delft, Nurse
Organizational Affiliation
Universitair Ziekenhuis Brussel
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Caitlin Jansen, Student
Organizational Affiliation
Vrije Universiteit Brussel
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Lissa De Potter, MD
Organizational Affiliation
Universitair Ziekenhuis Brussel
Official's Role
Study Chair
Facility Information:
Facility Name
Universitair Ziekenhuis Brussel
City
Jette
State/Province
Brussel
ZIP/Postal Code
1090
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Julie Lefevere, MD
Email
julie.lefevere@uzbrussel.be

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Database on non-invasive ventilation has the potential to be shared but no concrete plan for sharing individual patient data is made.
Citations:
PubMed Identifier
17989387
Citation
Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007 Nov 8;357(19):1946-55. doi: 10.1056/NEJMra067279. No abstract available.
Results Reference
background
PubMed Identifier
30974433
Citation
Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A, Plavka R, Roehr CC, Saugstad OD, Simeoni U, Speer CP, Vento M, Visser GHA, Halliday HL. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. Neonatology. 2019;115(4):432-450. doi: 10.1159/000499361. Epub 2019 Apr 11.
Results Reference
background
PubMed Identifier
34533644
Citation
Lefevere J, Van Delft B, Vervoort M, Cools W, Cools F. Non-invasive neurally adjusted ventilatory assist in preterm infants with RDS: effect of changing NAVA levels. Eur J Pediatr. 2022 Feb;181(2):701-707. doi: 10.1007/s00431-021-04244-3. Epub 2021 Sep 17.
Results Reference
background
PubMed Identifier
30905442
Citation
Harada E, Kinoshita M, Iwata S, Saikusa M, Tsuda K, Shindou R, Sahashi T, Kato S, Yamada Y, Saitoh S, Iwata O. Visual function scale for identification of infants with low respiratory compliance. Pediatr Neonatol. 2019 Dec;60(6):611-616. doi: 10.1016/j.pedneo.2019.02.006. Epub 2019 Mar 2.
Results Reference
background
PubMed Identifier
33246967
Citation
Thomson J, Ruegger CM, Perkins EJ, Pereira-Fantini PM, Farrell O, Owen LS, Tingay DG. Regional ventilation characteristics during non-invasive respiratory support in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2021 Jul;106(4):370-375. doi: 10.1136/archdischild-2020-320449. Epub 2020 Nov 27.
Results Reference
background
PubMed Identifier
30127522
Citation
Raimondi F, Yousef N, Migliaro F, Capasso L, De Luca D. Point-of-care lung ultrasound in neonatology: classification into descriptive and functional applications. Pediatr Res. 2021 Sep;90(3):524-531. doi: 10.1038/s41390-018-0114-9. Epub 2018 Jul 20.
Results Reference
background
PubMed Identifier
32458563
Citation
Alonso-Ojembarrena A, Ruiz-Gonzalez E, Estepa-Pedregosa L, Armenteros-Lopez AI, Segado-Arenas A, Lubian-Lopez SP. Reproducibility and reference values of diaphragmatic shortening fraction for term and premature infants. Pediatr Pulmonol. 2020 Aug;55(8):1963-1968. doi: 10.1002/ppul.24866. Epub 2020 Jun 5.
Results Reference
background

Learn more about this trial

Non-invasive Ventilation in Preterm Infants

We'll reach out to this number within 24 hrs